CDX-1140 : A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies

Investigator: Maen Abdelrahim, MD

Study Coordinator: Michelle Prystash

Status: Enrolling

ClinicalTrials.gov Number: NCT03329950

Phone: 713.441.6564

Protocol Number: Pro00020292

Description

This is a study to determine the maximum tolerated dose (MTD) for CDX-1140, either alone or in combination with CDX-301, and to further evaluate its tolerability and efficacy in expansion cohorts once the MTD is determined.
More to Explore
Live Chat Available